Balamapimod, also known as MKI-822, is a small-molecule Ras/Raf/MEK inhibitor that directly targets deregulated MAPK signaling cascades and is being actively explored to suppress aberrant protein kinase activity implicated in oncogenic transformation, inflammatory signaling, and pathological cell proliferation, with demonstrated therapeutic relevance for stroke, osteoporosis, rheumatoid arthritis, polycystic kidney disease, colonic polyps, and other inflammation-driven disorders through pathway-level inhibition.
Molecular Weight:
574.14
CAS Number:
[863029-99-6]
Formula:
C30H32ClN7OS
Target:
MEK|||Raf|||Ras
T16100
T16100
* VAT and and shipping costs not included. Errors and price changes excepted
